Table 1.
Treatment with Diet Referral and/or Metformin Prescription Within 1 Year from PCP Visit After Prediabetes Diagnosis During 2011–2018
| None | Referral | Metformin | Both | p | |
|---|---|---|---|---|---|
| 13,856 (82.9%) | 1548 (9.3%) | 976 (5.8%) | 333 (2%) | ||
| Age (mean (SD)) | 62.3 (12.8) | 56.8 (12.1) | 54.7 (12.1) | 52.8 (11.4) | < 0.001 |
| Female (%) | 7165 (51.7) | 1017 (65.7) | 609 (62.4) | 238 (71.5) | < 0.001 |
| Race (%) | < 0.001 | ||||
| White | 11,022 (79.5) | 1029 (66.5) | 753 (77.2) | 216 (64.9) | |
| Black | 2014 (14.5) | 427 (27.6) | 175 (17.9) | 103 (30.9) | |
| Other | 820 (5.9) | 92 (5.9) | 48 (4.9) | 14 (4.2) | |
| BMI (mean (SD)) | 32.8 (6.1) | 36.2 (7.8) | 35.9 (7.6) | 39.2 (8.4) | < 0.001 |
| HbA1c (mean (SD)) | 5.94 (0.19) | 5.96 (0.19) | 6.02 (0.21) | 6.01 (0.21) | < 0.001 |
| Smoker (%) | 1784 (12.9) | 156 (10.1) | 131 (13.4) | 38 (11.4) | 0.012 |
| Prediabetes diagnosis (%) | 9588 (69.2) | 1310 (84.6) | 818 (83.8) | 303 (91.0) | < 0.001 |
| Follow-up time (years) | 2.8 (2.1) | 4.0 (2.3) | 3.5 (2.2) | 4.4 (2.2) | < 0.001 |
BMI body mass index, HbA1c hemoglobin A1c